Forth raises £250k from the Development Bank of Wales to fund European expansion
The equity investment follows an introduction by business angel Craig Gulliford.
Forth provides biochemistry tracking and health insights with a focus on female hormonal health.
Forth has secured £250k in equity financing from the Development Bank of Wales, alongside backing from business angel Craig Gulliford. The Chepstow-based business provides at-home biomarker testing kits for general health and sports performance, operating both consumer ranges and specialised services for endurance athletes.
Following the capital injection, the company plans to fund its expansion into European markets. The transaction follows steady commercial growth and adoption of its web portal and mobile app dashboards.
From the founder
"People want to gain more insight into their own health in order to reach their personal best. Our results dashboard is intuitive and easy to understand so that we can empower the consumer to understand more about their own body. Results of the at-home tests are processed within 48 hours via a personalised dashboard and I am proud to say that we are the only biomarker profiling company to offer our customer a mobile app."
Sarah Bolt
CEO and Co-founder at Forth
Investor perspective
"Forth has made exciting progress since Sarah and her team relocated their headquarters to Wales. They have great products backed by scientific expertise. Sarah’s passion to improve people’s health is impressive and we’re pleased she is part of our growing portfolio of businesses founded by entrepreneurial women. It’s a pleasure to continue working with Craig following the success of Creo and to see him share his expertise with another exciting Welsh tech venture."
Richard Thompson
Senior Investment Executive, Development Bank of Wales
Use of funds
- 01Expand into international markets
